These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 595489)

  • 1. [Interaction of immobilized carboxypeptidase with a natural inhibitor from human blood plasma].
    Trapeznikova SS; Gontar' ID
    Vopr Med Khim; 1977; (6):840-4. PubMed ID: 595489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
    Islam I; Bryant J; May K; Mohan R; Yuan S; Kent L; Morser J; Zhao L; Vergona R; White K; Adler M; Whitlow M; Buckman BO
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1349-54. PubMed ID: 17189688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of kininases.
    Erdös EG
    Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
    [No Abstract]   [Full Text] [Related]  

  • 4. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.
    Arolas JL; Popowicz GM; Lorenzo J; Sommerhoff CP; Huber R; Aviles FX; Holak TA
    J Mol Biol; 2005 Jul; 350(3):489-98. PubMed ID: 15961103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of captopril and reserpine on the activity of certain neuropeptide metabolism enzymes].
    Gengin MT; Vernigora AN; Nikishin NN; Makeeva NV
    Vopr Med Khim; 1995; 41(5):37-9. PubMed ID: 8553625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["In vitro" protaminase activity of human plasma and serum and the human carboxypeptidase N (author's transl)].
    Blass J; Verriest C; Vicaigne MB; Weiss M
    Pathol Biol (Paris); 1980 Oct; 28(8):527-34. PubMed ID: 6448971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N.
    Hendriks D; Scharpé S; van Sande M; Lommaert MP
    J Clin Chem Clin Biochem; 1989 May; 27(5):277-85. PubMed ID: 2760564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a new arginine carboxypeptidase in human serum.
    Hendriks D; Wang W; Scharpé S; Lommaert MP; van Sande M
    Biochim Biophys Acta; 1990 Apr; 1034(1):86-92. PubMed ID: 2328266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N.
    Plummer TH; Ryan TJ
    Biochem Biophys Res Commun; 1981 Jan; 98(2):448-54. PubMed ID: 7225104
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N.
    Abendschein DR; Serota H; Plummer TH; Amiraian K; Strauss AW; Sobel BE; Jaffe AS
    J Lab Clin Med; 1987 Dec; 110(6):798-806. PubMed ID: 3681119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protaminase activity of plasma. III. Role of conversion enzyme (kininase II) in protaminase activity of plasma].
    Blass J; Detruit H; Aime L; Fiancette JY; Gaillard M; Verriest C; Vicaigne MB; Weiss M
    Pathol Biol (Paris); 1988 Dec; 36(10):1192-8. PubMed ID: 2853323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells.
    Kamada MM; Michon J; Ritz J; Holldack J; Serafin WE; Austen KF; MacDermott RP; Stevens RL
    J Immunol; 1989 Jan; 142(2):609-15. PubMed ID: 2911013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation, purification and properties of a carboxypeptidase inhibitor from human blood serum].
    Trapeznikova SS; Mardashev SR
    Vopr Med Khim; 1975; 21(4):417-22. PubMed ID: 1216761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E; Gora-Maslak G
    Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enzyme immobilization on hydroxyalkylmethacrylate carrier Separon E - properties of immobilized enzymes and their prospective uses in medicine (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Sep; 119(39):1055-7. PubMed ID: 7002314
    [No Abstract]   [Full Text] [Related]  

  • 18. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
    Vernigora AN; Nikishin NN; Gengin MT
    Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilization of urea cycle enzymes. II. Characterization of immobilized argininosuccinate synthetase.
    Miura Y; Miyamoto K; Urabe H; Nagata C; Hane Y
    J Biomed Mater Res; 1977 Sep; 11(5):755-66. PubMed ID: 893492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.